Article
Evaluation of the Effect of Ritlecitinib on the Pharmacokinetics of Caffeine in Healthy Participants
2022-10-22
Abstract excerpt
<h4>Objective: </h4> This clinical study was conducted to evaluate the impact of ritlecitinib on the pharmacokinetics (PK) of caffeine, a cytochrome P450 1A2 (CYP1A2) substrate. <h4>Methods:</h4> In this single-center, single-arm, open-label, fixed-sequence study, healthy participants received a single 100-mg dose of caffeine on two separate occasions: on Day 1 of Period 1 as monotherapy and on Day 8 of Period 2 a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ee1292bf-f256-51ef-94f8-5d839e0a85fb
- DOI
- 10.22541/au.166645623.32214629/v1
